Skip to main content
BCWORLDPHARM Co., Ltd. logo

BCWORLDPHARM Co., Ltd. — Investor Relations & Filings

Ticker · 200780 ISIN · KR7200780005 KO Manufacturing
Open in API
Filings indexed 192 across all filing types
Latest filing 2024-12-12 Notice of Dividend Amou…
Country KR South Korea
Listing KO 200780

About BCWORLDPHARM Co., Ltd.

https://www.bcwp.co.kr

BCWORLDPHARM Co., Ltd. is a technology-driven pharmaceutical company specializing in the research, development, and manufacturing of prescription drugs. The company leverages its core expertise in formulation and process development to produce a diverse portfolio of quality generic medicines. With a significant commitment to research and development, BCWORLDPHARM focuses on creating next-generation pharmaceuticals to address evolving medical needs and improve patient health outcomes.

Recent filings

Filing Released Lang Actions
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is an official announcement from BC World Pharm regarding a decision on cash dividends. It specifies the dividend amount per share, the dividend record date, and the approval process via the upcoming general meeting of shareholders. This aligns perfectly with the definition for 'Notice of Dividend Amount'.
2024-12-12 Korean
주식배당결정
Notice of Dividend Amount Classification · 100% confidence The document is an official announcement from BC World Pharm regarding a 'Stock Dividend Decision' (주식배당결정). It details the number of shares per dividend, the total number of shares, the record date, and the board resolution date. This falls under the category of dividend announcements, which is specifically defined as 'Notice of Dividend Amount' (DIV).
2024-12-12 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'BCWORLD PHARM. Co., Ltd.' covering the period from January 1, 2024, to September 30, 2024. It contains detailed financial data, business descriptions, and management information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-13 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) meeting (기업설명회). It provides details such as the date, time, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it does not fit into other specific categories like earnings releases or financial reports, it is classified as a regulatory filing announcement.
2024-10-14 Korean
[기재정정]반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for BCWORLD PHARM. Co., Ltd., covering the period from January 1, 2024, to June 30, 2024. It includes detailed financial statements, management discussions, and corporate governance information. Although it is labeled as a '정정신고' (Correction Report) regarding a specific table in the financial statements, it constitutes a comprehensive interim financial report as defined by the 'Interim / Quarterly Report' (IR) category. It contains substantive financial data and analysis, not just a notification of a report's existence. H1 2024
2024-08-21 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for BCWORLD PHARM. Co., Ltd. for the period ending June 30, 2024. It contains comprehensive financial statements, business overviews, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). H1 2024
2024-08-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.